These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 17404112)
21. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
22. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Kyprianou N; Benning CM Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806 [TBL] [Abstract][Full Text] [Related]
23. Expression of insulin-like growth factor binding protein-3 before and after neoadjuvant hormonal therapy in human prostate cancer tissues: correlation with histopathologic effects and biochemical recurrence. Miyata Y; Sakai H; Kanda S; Igawa T; Hayashi T; Kanetake H Urology; 2004 Jun; 63(6):1184-90. PubMed ID: 15183987 [TBL] [Abstract][Full Text] [Related]
24. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Zi X; Zhang J; Agarwal R; Pollak M Cancer Res; 2000 Oct; 60(20):5617-20. PubMed ID: 11059749 [TBL] [Abstract][Full Text] [Related]
25. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439 [TBL] [Abstract][Full Text] [Related]
26. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1. Degeorges A; Wang F; Frierson HF; Seth A; Chung LW; Sikes RA Cancer Res; 1999 Jun; 59(12):2787-90. PubMed ID: 10383131 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177 [TBL] [Abstract][Full Text] [Related]
28. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944 [TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models. Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666 [TBL] [Abstract][Full Text] [Related]
31. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway. Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581 [TBL] [Abstract][Full Text] [Related]
32. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002 [TBL] [Abstract][Full Text] [Related]
33. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282 [TBL] [Abstract][Full Text] [Related]
34. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802 [TBL] [Abstract][Full Text] [Related]
35. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029 [TBL] [Abstract][Full Text] [Related]
36. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329 [TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer. Koike H; Ito K; Takezawa Y; Oyama T; Yamanaka H; Suzuki K Br J Cancer; 2005 Apr; 92(8):1538-44. PubMed ID: 15846301 [TBL] [Abstract][Full Text] [Related]
38. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915 [TBL] [Abstract][Full Text] [Related]
39. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Yu W; Sanders BG; Kline K Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702 [TBL] [Abstract][Full Text] [Related]
40. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]